Prognostic Significance of Initial r-Wave in Leads V1 and aVR Before PTSMA in Patients with Hypertrophic Obstructive Cardiomyopathy

References

• Ho CY, Lopez B, Coelho-Filho OR, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med. 2010;363:552–563. doi:10.1056/NEJMoa1002659
   PubMed Web of Science ®Google Scholar
• Steggerda RC, Damman K, Balt JC, et al. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy. JACC Cardiovasc Interv. 2014;7(11):1227–1234. doi:10.1016/j.jcin.2014.05.023
   PubMed Web of Science ®Google Scholar
• Faber L, Welge D, Fassbender D, et al. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol. 2007;96(12):864–873. doi:10.1007/s00392-007-0578-9
   PubMed Web of Science ®Google Scholar
• Maekawa Y, Jinzaki M, Anzai A, et al. Successful second attempt multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation for an octogenarian with hypertrophic obstructive cardiomyopathy. Int J Cardiol. 2014;176(3):e131–e132. doi:10.1016/j.ijcard.2014.07.211
   PubMed Web of Science ®Google Scholar
• Chang SM, Lakkis NM, Franklin J, et al. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2004;109(7):824–827. doi:10.1161/01.CIR.0000117089.99918.5A
   PubMed Web of Science ®Google Scholar
• Henein MY, O’Sullivan CA, Ramzy IS, et al. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1999;34(4):1117–1122. doi:10.1016/S0735-1097(99)00332-0
   PubMed Web of Science ®Google Scholar
• Kappenberger L, Linde C, Daubert C, et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J. 1997;18:1249–1256. doi:10.1093/oxfordjournals.eurheartj.a015435
   PubMed Web of Science ®Google Scholar
• Spach MS, Barr RC. Ventricular intramural and epicardial potential distributions during ventricular activation and repolarization in the intact dog. Circ Res. 1975;37:243–257. doi:10.1161/01.RES.37.2.243
   PubMed Web of Science ®Google Scholar
• Durrer D, van Dam RT, Freud GE, et al. Total excitation of the isolated human heart. Circulation. 1970;41(6):899–912. doi:10.1161/01.CIR.41.6.899
   PubMed Web of Science ®Google Scholar
• Gurjarpadhye A, Hewett KW, Justus C, et al. Cardiac neural crest ablation inhibits compaction and electrical function of conduction system bundles. Am J Physiol Heart Circ Physiol. 2007;292(3):H1291–H1300. doi:10.1152/ajpheart.01017.2006
   PubMed Web of Science ®Google Scholar
• Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–2779.
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Bierig SM, Budoff MJ, et al. American society of echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American society of nuclear cardiology, society for cardiovascular magnetic resonance, and society of cardiovascular computed tomography. J Am Soc Echocardiogr. 2011;24:473–498. doi:10.1016/j.echo.2011.03.006
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu R, Yuan J, et al. Significance and determinants of cardiac troponin I in patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2015;116(11):1744–1751. doi:10.1016/j.amjcard.2015.09.006
   PubMed Web of Science ®Google Scholar
• Bennett JA, Riegel B, Bittner V, et al. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung. 2002;31(4):262–270. doi:10.1067/mhl.2002.124554
   PubMed Web of Science ®Google Scholar
• Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346(8969):211–214. doi:10.1016/S0140-6736(95)91267-3
   PubMed Web of Science ®Google Scholar
• Sorajja P, Ommen SR, Holmes DJ, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126(20):2374–2380. doi:10.1161/CIRCULATIONAHA.111.076257
   PubMed Web of Science ®Google Scholar
• Veselka J, Krejci J, Tomasov P, et al. Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population. Eur Heart J. 2014;35:2040–2045. doi:10.1093/eurheartj/eht495
   PubMed Web of Science ®Google Scholar
• Batzner A, Pfeiffer B, Neugebauer A, et al. Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2018;72(24):3087–3094. doi:10.1016/j.jacc.2018.09.064
   PubMed Web of Science ®Google Scholar
• Steggerda RC, Balt JC, Damman K, et al. Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy. Neth Heart J. 2013;21(11):504–509. doi:10.1007/s12471-013-0453-4
   PubMed Web of Science ®Google Scholar
• Valeti US, Nishimura RA, Holmes DR, et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007;49(3):350–357. doi:10.1016/j.jacc.2006.08.055
   PubMed Web of Science ®Google Scholar
• Tamura A, Kataoka H, Mikuriya Y. Electrocardiographic findings in a patient with pure septal infarction. Br Heart J. 1991;65:166–167. doi:10.1136/hrt.65.3.166
   PubMedGoogle Scholar
• Xiao HB, Gibson DG. Absent septal q wave: a marker of the effects of abnormal activation pattern on left ventricular diastolic function. Br Heart J. 1994;72:45–51. doi:10.1136/hrt.72.1.45
   PubMedGoogle Scholar
• Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 1998;31(2):252–258. doi:10.1016/S0735-1097(97)00508-1
   PubMed Web of Science ®Google Scholar
• Ruzyllo W, Chojnowska L, Demkow M, et al. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy. Eur Heart J. 2000;21:770–777. doi:10.1053/euhj.1999.1905
   PubMed Web of Science ®Google Scholar
• Chojnowska L, Ruzyllo W, Witkowski A, et al. Early and long-term results of non-surgical septal reduction in patients with hypertrophic cardiomyopathy. Kardiol Pol. 2003;59:269–282.
   PubMedGoogle Scholar
• Kim JJ, Lee CW, Park SW, et al. Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy. Am J Cardiol. 1999;83:1220–1223. doi:10.1016/S0002-9149(99)00063-6
   PubMed Web of Science ®Google Scholar